Providing market intelligence for more than 35 years

In The News

Sliver.tv rakes in $9.8M in funding, advances VR broadcasting technology

A recent report from Parks Associates suggested AI’s benefits can be extended beyond content production and enhancement.

“AI-enabled systems will also be increasingly used in content creation decisions, revealing topical areas or genre-related trends that have previously gone unnoticed in the noise of big data,” Parks said in a recent report. “Using these tools will allow producers and distributors to better predict and fund content that will draw audiences.”

At the heart of Sliver.tv's approach is its patented virtual camera array technology that captures 2D games played on a PC such as "Counter Strike: Global Offensive" and "League of Legends," and renders in real-time a fully immersive 360° in-world stream.

From the article "Sliver.tv rakes in $9.8M in funding, advances VR broadcasting technology" by Sean Buckley.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...